Seagen Company Profile
✉ Email this page to a colleague
Biologic Drugs for Seagen
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Seagen Inc. | ADCETRIS | brentuximab vedotin | For Injection | 125388 | 10,022,451 | 2035-05-11 | Patent claims search |
| Seagen Inc. | ADCETRIS | brentuximab vedotin | For Injection | 125388 | 10,065,934 | 2035-07-16 | Patent claims search |
| Seagen Inc. | ADCETRIS | brentuximab vedotin | For Injection | 125388 | 10,111,968 | 2036-08-10 | Patent claims search |
| Seagen Inc. | ADCETRIS | brentuximab vedotin | For Injection | 125388 | 10,159,675 | 2036-12-01 | Patent claims search |
| Seagen Inc. | ADCETRIS | brentuximab vedotin | For Injection | 125388 | 10,179,183 | 2037-05-30 | DrugPatentWatch analysis and company disclosures |
| Seagen Inc. | ADCETRIS | brentuximab vedotin | For Injection | 125388 | 10,201,615 | 2036-01-27 | Patent claims search |
| Seagen Inc. | ADCETRIS | brentuximab vedotin | For Injection | 125388 | 10,259,859 | 2036-08-05 | Patent claims search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
Similar Applicant Names
This search can help find similar names.
